Keay Nakae
Stock Analyst at Chardan Capital
(0.24)
# 2043
Out of 5,240 analysts
242
Total ratings
30.29%
Success rate
5.71%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Dyne Therapeutics | Maintains: Buy | 50 50 | 15 | 233.33% | 8 | Jan 10, 2025 | |
Sonnet BioTherapeuti... | Maintains: Buy | 30 20 | 1.51 | 1224.5% | 12 | Dec 20, 2024 | |
ProQR Therapeutics | Maintains: Buy | 4 4 | 2.27 | 76.21% | 13 | Dec 12, 2024 | |
Arrowhead Pharma | Maintains: Buy | 60 60 | 18.04 | 232.59% | 17 | Dec 12, 2024 | |
Silence Therapeutics | Maintains: Buy | 55 55 | 5.63 | 876.91% | 10 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 5 5 | 3.19 | 56.74% | 11 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 2 2 | 0.77 | 62.34% | 8 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 8 | 1.05 | 661.9% | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 20 20 | 5.26 | 280.23% | 7 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 65 65 | 26.99 | 140.83% | 12 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14 14 | 5.77 | 142.63% | 14 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 25 | 3.57 | 600.28% | 12 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 300 300 | 240.92 | 24.52% | 10 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 6 6 | 2.08 | 188.46% | 6 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 7 6 | 0.59 | 916.95% | 6 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 5 | 2.71 | 84.5% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 7 5 | n/a | n/a | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 5 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 9 | n/a | n/a | 6 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 8 6 | 16.98 | -64.66% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 8 | n/a | n/a | 5 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 50 | n/a | n/a | 4 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 60 20 | 0.72 | 2677.78% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 65 55 | 9.37 | 486.98% | 10 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 175 125 | n/a | n/a | 4 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 5 | Oct 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 2 10 | 8.84 | 13.12% | 5 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 3 2 | n/a | n/a | 4 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 28 39 | n/a | n/a | 4 | Dec 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 100 88 | 14.57 | 500.55% | 2 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 1 13 | 0.73 | 1680.82% | 3 | Feb 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 155 40 | 2.17 | 1743.32% | 2 | Jun 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Terminates Coverage On: Buy | 3 0 | n/a | n/a | 3 | May 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 65 70 | n/a | n/a | 2 | Mar 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 22500 | n/a | n/a | 1 | Jun 2, 2017 |